These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32195950)

  • 1. Treatment of herpes labialis by photodynamic therapy: Study protocol clinical trial (SPIRIT compliant).
    La Selva A; Negreiros RM; Bezerra DT; Rosa EP; Pavesi VCS; Navarro RS; Bello-Silva MS; Ramalho KM; Aranha ACC; Braz-Silva PH; Fernandes KPS; Bussadori SK; Horliana ACRT
    Medicine (Baltimore); 2020 Mar; 99(12):e19500. PubMed ID: 32195950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of photodynamic therapy as an adjunct to topical antiviral therapy in the treatment of herpes labialis: A randomized controlled clinical trial.
    Ajmal M
    Photodiagnosis Photodyn Ther; 2021 Jun; 34():102302. PubMed ID: 33894370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.
    Spruance SL; Rea TL; Thoming C; Tucker R; Saltzman R; Boon R
    JAMA; 1997 May; 277(17):1374-9. PubMed ID: 9134943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for a randomised controlled trial of 90% kanuka honey versus 5% aciclovir for the treatment of herpes simplex labialis in the community setting.
    Semprini A; Singer J; Shortt N; Braithwaite I; Beasley R;
    BMJ Open; 2017 Aug; 7(8):e017766. PubMed ID: 28775197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes Labialis: An Update.
    Leung AKC; Barankin B
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(2):107-113. PubMed ID: 28971780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials.
    Spruance SL; Nett R; Marbury T; Wolff R; Johnson J; Spaulding T
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2238-43. PubMed ID: 12069980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy and Acyclovir in the treatment of recurrent herpes labialis: A controlled randomized clinical trial.
    Ramalho KM; Cunha SR; Gonçalves F; Escudeiro GS; Steiner-Oliveira C; Horliana ACRT; Eduardo CP
    Photodiagnosis Photodyn Ther; 2021 Mar; 33():102093. PubMed ID: 33212267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis.
    Evans TG; Bernstein DI; Raborn GW; Harmenberg J; Kowalski J; Spruance SL
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1870-4. PubMed ID: 12019102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Penciclovir Cream Herpes Labialis Study Group.
    Boon R; Goodman JJ; Martinez J; Marks GL; Gamble M; Welch C
    Clin Ther; 2000 Jan; 22(1):76-90. PubMed ID: 10688392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies.
    Baker D; Eisen D
    Cutis; 2003 Mar; 71(3):239-42. PubMed ID: 12661753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis.
    Hull CM; Brunton S
    Postgrad Med; 2010 Sep; 122(5):1-6. PubMed ID: 20873400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes labialis in skiers: randomized clinical trial of acyclovir cream versus placebo.
    Raborn GW; Martel AY; Grace MG; McGaw WT
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Dec; 84(6):641-5. PubMed ID: 9431533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of recurrent herpes simplex labialis with oral acyclovir.
    Spruance SL; Stewart JC; Rowe NH; McKeough MB; Wenerstrom G; Freeman DJ
    J Infect Dis; 1990 Feb; 161(2):185-90. PubMed ID: 2153735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silica gel is as effective as acyclovir cream in patients with recurrent herpes labialis: results of a randomized, open-label trial.
    Zschocke I; Reich C; Zielke A; Reitmeier N; Reich K
    J Dermatolog Treat; 2008; 19(3):176-81. PubMed ID: 18569274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis.
    Spruance SL
    J Med Virol; 1993; Suppl 1():27-32. PubMed ID: 8245889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent approval of Xerese in Canada: 5% acyclovir and 1% hydrocortisone topical cream in the treatment of herpes labialis.
    Nguyen HP; Stiegel KR; Downing C; Stiegel KR
    Skin Therapy Lett; 2014; 19(3):5-8. PubMed ID: 25188362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial.
    Rooney JF; Straus SE; Mannix ML; Wohlenberg CR; Alling DW; Dumois JA; Notkins AL
    Ann Intern Med; 1993 Feb; 118(4):268-72. PubMed ID: 8380540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyclovir cream prevents clinical and thermographic progression of recrudescent herpes labialis beyond the prodromal stage.
    Biagioni PA; Lamey PJ
    Acta Derm Venereol; 1998 Jan; 78(1):46-7. PubMed ID: 9498027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients.
    You Y; Wang L; Li Y; Wang Q; Cao S; Tu Y; Li S; Bai L; Lu J; Wei Z; Chen W; Hao F
    J Dermatol; 2015 Jun; 42(6):596-601. PubMed ID: 25819042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance for antiviral-agent-resistant herpes simplex virus in the general population with recurrent herpes labialis.
    Bacon TH; Boon RJ; Schultz M; Hodges-Savola C
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3042-4. PubMed ID: 12183267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.